Institute of Infection, Immunity & Inflammation, University of Glasgow (UK)

Hugh Willison

Biosketch

Professor Hugh J. Willison directs the Neuroimmunology Research Group at the University of Glasgow, Scotland. He also practices clinical neurology and directs a Diagnostic Neuroimmunology service within the South Glasgow University Hospitals. He has a specialist clinical interest in the diagnosis and management of patients with autoimmune peripheral nerve disorders. His research on autoimmune neuropathy involves pathogenesis studies and novel treatment strategies for the severe paralytic disorder, Guillain-Barré syndrome, which was first described 101 years ago, in 1916. He currently has a particular interest in understanding Guillain-Barré syndrome that follows Zika virus and other flavivirus infections. He teaches widely, being a founding board member and co-director of the European School of Neuroimmunology (http://www.esni.isniweb.org/) which recently expanded to organise teaching courses worldwide. He is on the executive board of a worldwide effort to promote research and teaching into Guillain-Barré syndrome, termed the IGOS network, which is seeking to develop research sites in India. In 2015, he was awarded the Alan J Gebhart Prize for Excellence in Peripheral Nerve Research by the Peripheral Nerve Society. He is a Fellow of the Royal Society of Edinburgh. His research is principally funded by the Wellcome Trust and the European Union.